- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS) ; volume:25 ; number:12 ; day:28 ; month:11 ; year:2023 ; pages:939-946 ; date:12.2023
Current atherosclerosis reports ; 25, Heft 12 (28.11.2023), 939-946, 12.2023
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11883-023-01163-6
- URN
-
urn:nbn:de:101:1-2024031821542277044753
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arnold, Natalie
- Koenig, Wolfgang
- SpringerLink (Online service)
Ähnliche Objekte (12)
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024
Optimal lipid-lowering therapy in patients who were functionally deferred percutaneous coronary intervention
Acute Coronary Syndromes in Women
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes - a substudy of the TROPICAL-ACS trial
ACS
ACS
ACS
ACS
ACS
ACS
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024
Optimal lipid-lowering therapy in patients who were functionally deferred percutaneous coronary intervention
Acute Coronary Syndromes in Women
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes - a substudy of the TROPICAL-ACS trial
ACS
ACS
ACS
ACS
ACS
ACS
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024
Optimal lipid-lowering therapy in patients who were functionally deferred percutaneous coronary intervention
Acute Coronary Syndromes in Women
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes - a substudy of the TROPICAL-ACS trial
ACS
ACS
ACS
ACS
ACS